Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy in Participants With Selected Advanced Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 13, 2023
Preserving Erectile Function by Quantifying the Nerve-Sparing Step of the Robotic Prostatectomy
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 13, 2023
Art Therapy in a hematology/oncology/bone marrow transplant clinics for Pediatric, Adolescent, and Young Adult patients: A pilot multi-site mixed methods observational study
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 13, 2023
A Phase 1b/2a Study of Gemcitabine and Nab-paclitaxel in Combination with Avutometinib (VS-6766) and Defactinib in Patients with Previously Untreated Metastatic Adenocarcinoma of the Pancreas
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 19, 2023
A Phase IIb, Open-label, Randomized Study of Nab-Paclitaxel and Gemcitabine plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 19, 2023
Study Evaluating Metastatic Castrate Resistant Prostate Cancer Treatment Using 177Lu-PNT2002 PSMA Therapy After Second-line Hormonal Treatment
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 19, 2023
Pilot Study of PSMA-TRT Re-treatment Utilizing 225Ac-J591
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 19, 2023
A Phase II/III Randomized Study of R-MiniCHOP with or Without CC-486 in Participants Age 75 Years or Older with Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 2, 2023
A Phase Ib Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 2, 2023
APEC1621C NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE) SCREENING PROTOCOL
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 2, 2023
« first
‹ previous
…
17
18
19
20
21
(current)
22
23
24
25
…
next ›
last »